Cancer patients develop cachexia due to systemic inflammation, negative p rotein and energy balance. Esperer Onco Nutrition (EON) has come up with innovative nutritional supplements (EON Therapy) that help patients take the rigours of cancer therapy thereby improving prognosis and Quality of Life (QoL). This Post-marketing surveillance study was undertaken o n 38 volunteers to assess the impact of EON therapy on cachexia and QoL of patients undergoing curative treatment. Body weight and biochemical parameters of the volunteers were recorded at each visit. Volunteers were assessed using ECOG Scale and Malnutrition Screening Tool (MST) to assess impact of nutritional supplements on QoL. Weight loss was observed in most of the patients for first two visits but the patients gained weight over subsequent visits and average weight at end of the study was higher than initial weight. At the end of study 22 of 38 volunteers gained weight and 7 volunteers maintained initial weight. The biochemical parameters either showed improvement or remained same. The QoL analysis indicated a marked improvement in physical wellness and nutritional status and no adverse effects were reported. In conclusion, the study underlines importance of research based on nutritional supplements for cancer patients for better disease management and prognosis.
KeywordsCancerCachexiaNutritional InterventionQuality of Life
Porporato, P.E. (2016) Understanding Cachexia as a Cancer Metabolism Syndrome. Oncogenesis, 5, Article No. e200. https://doi.org/10.1038/oncsis.2016.3
Marceca, G.P., Londhe, P. and Calore, F. (2020) Management of Cancer Cachexia: Attempting to Develop New Pharmacological Agents for New Effective Therapeutic Options. Frontiers in Oncology, 10, Article No. 298. https://doi.org/10.3389/fonc.2020.00298
Hébuterne, X., Lemarié, E., Michallet, M., de Montreuil, C.B., Schneider, S.M. and Goldwasser, F. (2014) Prevalence of Malnutrition and Current Use of Nutrition Support in Patients with Cancer. Journal of Parenteral and Enteral Nutrition, 38, 196-204. https://doi.org/10.1177/0148607113502674
Bruggeman, A.R., Kamal, A.H., LeBlanc, T.W., Ma, J.D., Baracos, V.E. and Roeland, E.J. (2016) Cancer Cachexia: Beyond Weight Loss. Journal of Oncology Practice, 12, 1163-1171. https://doi.org/10.1200/JOP.2016.016832
Arends, J., Baracos, V., Bertz, H., Bozzetti, F., Calder, P.C., Deutz, N.E.P., Erickson, N., et al. (2017) ESPEN Expert Group Recommendations for Action against Cancer-Related Malnutrition. Clinical Nutrition, 36, 1187-1196. https://doi.org/10.1016/j.clnu.2017.06.017
Lu, Z., Yang, L., Yu, J., Lu, M., Zhang, X., Li, J., Zhou, J., Wang, X., Gong, J., Gao, J., Li, J., Li, Y. and Shen, L. (2014) Change of Body Weight and Macrophage Inhibitory Cytokine-1 during Chemotherapy in Advanced Gastric Cancer: What Is Their Clinical Significance? PLoS ONE, 9, Article ID: e88553. https://doi.org/10.1371/journal.pone.0088553
Arends, J., Bachmann, P., Baracos, V., Barthelemy, N., Bertz, H., Bozzetti, F., Fearon, K., Hütterer, E., Isenring, E., Kaasa, S., Krznaric, Z., Laird, B., Larsson, M., Laviano, A., Mühlebach, S., Muscaritoli, M., Oldervoll, L., Ravasco, P., Solheim, T., Strasser, F., de van der Schueren, M. and Preiser, J.C. (2017) ESPEN Guidelines on nutrition in cancer patients. Clinical Nutrition, 36, 11-48. https://doi.org/10.1016/j.clnu.2016.07.015
Fearon, K., Arends, J. and Baracos, V. (2013) Understanding the Mechanisms and Treatment Options in Cancer Cachexia. Nature Review Clinical Oncology, 10, 90-99. https://doi.org/10.1038/nrclinonc.2012.209
Aapro, M., Arends, J., Bozzetti, F., Fearon, K., Grunberg, S.M., Herrstedt, J., Hopkinson, J., Jacquelin-Ravel, N., Jatoi, A., Kaasa, S. and Strasser F. (2014) Early Recognition of Malnutrition and Cachexia in the Cancer Patient: A Position Paper of a European School of Oncology Task Force. Annals of Oncology, 25, 1492-1499. https://doi.org/10.1093/annonc/mdu085
Bozzetti, F., Arends, J., Lundholm, K., Micklewright, A., Zurcher, G. and Muscaritoli, M. (2009) ESPEN Guidelines on Parenteral Nutrition: Non-Surgical Oncology. Clinical Nutrition, 28, 445-454. https://doi.org/10.1016/j.clnu.2009.04.011
Cotogni, P., Pedrazzoli, P., De Waele, E., Aprile, G., Farina, G., Stragliotto, S., De Lorenzo, F. and Caccialanza, R. (2019) Nutritional Therapy in Cancer Patients Receiving Chemoradiotherapy: Should We Need Stronger Recommendations to Act for Improving Outcomes? Journal of Cancer, 10, 4318-4325. https://doi.org/10.7150/jca.31611
Cotogni, P. (2016) Enteral versus Parenteral Nutrition in Cancer Patients: Evidences and Controversies. Annals of Palliative Medicine, 5, 42-49.
August, D.A. and Huhmann, M.B. (2009) ASPEN Clinical Guidelines: Nutrition Support Therapy during Adult Anticancer Treatment and in Hematopoietic Cell Transplantation. Journal of Parenteral and Enteral Nutrition, 33, 472-500. https://doi.org/10.1177/0148607109341804
Yalcin, S., Gumus, M., Oksuzoglu, B., Ozdemir, F., Evrensel, T., Sarioglu, A.A., Sahin, B., Mandel, N.M. and Goker, E. (2019) Nutritional Aspect of Cancer Care in Medical Oncology Patients. Clinical Therapy, 41, 2382-2396. https://doi.org/10.1016/j.clinthera.2019.09.006
Azam, F., Latif, M.F., Farooq, A., Tirmazy, S.H., AlShahrani, S., Bashir, S. and Bukhari, N. (2019) Performance Status Assessment by Using ECOG (Eastern Cooperative Oncology Group) Score for Cancer Patients by Oncology Healthcare Professionals. Case Reports in Oncology, 12, 728-736. https://doi.org/10.1159/000503095
Di Bella, A., Croisier, E., Blake, C., Pelecanos, A., Bauer, J. and Brown, T. (2020) Assessing the Concurrent Validity and Interrater Reliability of Patient-Led Screening Using the Malnutrition Screening Tool in the Ambulatory Cancer Care Outpatient Setting. Journal of the Academy of Nutrition and Dietetics, 120, 1210-1215. https://doi.org/10.1016/j.jand.2019.10.015
Kubrak, C., Olson, K., Jha, N., Jensen, L., McCargar, L., Seikaly, H., Harris, J., Scrimger, R., Parliament, M. and Baracos, V.E. (2010) Nutrition Impact Symptoms: Key Determinants of Reduced Dietary Intake, Weight Loss, and Reduced Functional Capacity of Patients with Head and Neck Cancer before Treatment. Head Neck, 32, 290-300. https://doi.org/10.1002/hed.21174
Batista, G.A., Souza, A.L., Marin, D.M., Sider, M., Melhado, V.C., Fernandes, A.M. and Alegre, S.M. (2017) Body Composition, Resting Energy Expenditure and Inflammatory Markers: Impact in Users of Depot Medroxyprogesterone Acetate after 12 Months Follow-Up. Archives of Endocrinology and Metabolism, 61, 70-75. https://doi.org/10.1590/2359-3997000000202
Akbulut, G. (2011) New Perspective for Nutritional Support of Cancer Patients: Enteral/Parenteral Nutrition. Experimental and Therapeutic Medicine, 2, 675-684. https://doi.org/10.3892/etm.2011.247
Tan, B.H., Birdsell, L.A., Martin, L., Baracos, V.E. and Fearon K.C. (2009) Sarcopenia in An Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer. Clinical Cancer Research, 15, 6973-6979. https://doi.org/10.1158/1078-0432.CCR-09-1525
Prado, C.M., Lieffers, J.R., McCargar, L.J., Reiman, T., Sawyer, M.B., Martin, L. and Baracos V.E. (2008) Prevalence and Clinical Implications of Sarcopenic Obesity in Patients with Solid Tumours of the Respiratory and Gastrointestinal Tracts: A Population-Based Study. The Lancet Oncology, 9, 629-635. https://doi.org/10.1016/S1470-2045(08)70153-0
Prado, C.M., Antoun, S., Sawyer, M.B. and Baracos, V.E. (2011) Two Faces of Drug Therapy in Cancer: Drug-Related Lean Tissue Loss and Its Adverse Consequences to Survival and Toxicity. Current Opinion in Nutrition and Metabolic Care, 14, 250-254. https://doi.org/10.1097/MCO.0b013e3283455d45
Mir, O., Coriat, R., Blanchet, B., Durand, J.P., Boudou-Rouquette, P., Michels, J., Ropert, S., Vidal, M., Pol, S., Chaussade, S. and Goldwasser, F. (2012) Sarcopenia Predicts Early Dose-Limiting Toxicities and Pharmacokinetics of Sorafenib in Patients with Hepatocellular Carcinoma. PLoS ONE, 7, Article ID: e37563. https://doi.org/10.1371/journal.pone.0037563
Zhao, H., Wu, L., Yan, G., Chen, Y., Zhou, M., Wu, Y. and Li, Y. (2021) Inflammation and Tumor Progression: Signaling Pathways and Targeted Intervention. Signal Transduction and Targeted Therapy, 6, Article No. 263. https://doi.org/10.1038/s41392-021-00658-5
Greten, F.R. and Grivennikov, S.I. (2019) Inflammation and Cancer: Triggers, Mechanisms, and Consequences. Immunity, 51, 27-41. https://doi.org/10.1016/j.immuni.2019.06.025
Hanahan, D. and Weinberg R.A. (2011) Hallmarks of Cancer: The Next Generation. Cell, 144, 646-674. https://doi.org/10.1016/j.cell.2011.02.013
Straub, R.H. (2012) Evolutionary Medicine and Chronic Inflammatory State—Known and New Concepts in Pathophysiology. Journal of Molecular Medicine, 90, 523-534. https://doi.org/10.1007/s00109-012-0861-8
Winter, A., MacAdams, J. and Chevalier, S. (2012) Normal Protein Anabolic Response to Hyperaminoacidemia in Insulin-Resistant Patients with Lung Cancer Cachexia. Clinical Nutrition, 31, 765-773. https://doi.org/10.1016/j.clnu.2012.05.003
Straub, R.H., Cutolo, M., Buttgereit, F. and Pongratz G. (2010) Energy Regulation and Neuroendocrine-Immune Control in Chronic Inflammatory Diseases. Journal of Internal Medicine, 267, 543-560. https://doi.org/10.1111/j.1365-2796.2010.02218.x
Honors, M.A. and Kinzig, K.P. (2012) The Role of Insulin Resistance in the Development of Muscle Wasting during Cancer Cachexia. Journal of Cachexia, Sarcopenia and Muscle, 3, 5-11. https://doi.org/10.1007/s13539-011-0051-5
Aoyagi, T., Terracina, K.P., Raza, A., Matsubara, H. and Takabe, K. (2015) Cancer Cachexia, Mechanism and Treatment. World J Gastrointestinal Oncology, 7, 17-29. https://doi.org/10.4251/wjgo.v7.i4.17
Tan, B.H., Fladvad, T., Braun, T.P., Vigano, A., Strasser, F., Deans, D.A., Skipworth, R.J., Solheim, T.S., Damaraju, S., Ross, J.A., Kaasa, S., Marks, D.L., Baracos, V.E., Skorpen, F. and Fearon, K.C. (2012) P-Selectin Genotype Is Associated with the Development of Cancer Cachexia. EMBO Molecular Medicine, 4, 462-471. https://doi.org/10.1002/emmm.201200231
Das, S.K., Eder, S., Schauer, S., Diwoky, C., Temmel, H., Guertl, B., Gorkiewicz, G., Tamilarasan, K.P., Kumari, P., Trauner, M., Zimmermann, R., Vesely, P., Haemmerle, G., Zechner, R. and Hoefler G. (2011) Adipose Triglyceride Lipase Contributes to Cancer-Associated Cachexia. Science, 333, 233-238. https://doi.org/10.1126/science.1198973
Arends, J. (2018) Struggling with Nutrition in Patients with Advanced Cancer: Nutrition and Nourishment—Focusing on Metabolism and Supportive care. Annals of Oncology, 29, ii27-ii34. https://doi.org/10.1093/annonc/mdy093
Giordano, A. and Tommonaro, G. (2019) Curcumin and Cancer. Nutrients, 11, Article No. 2376. https://doi.org/10.3390/nu11102376
Kawata, A., Murakami, Y., Suzuki, S. and Fujisawa, S. (2018) Anti-Inflammatory Activity of β-Carotene, Lycopene and Tri-n-Butylborane, a Scavenger of Reactive Oxygen Species. In Vivo, 32, 255-264. https://doi.org/10.21873/invivo.11232
Lee, J.H., Park, E., Jin, H.J., Lee, Y., Choi, S.J., Lee, G.W., Chang, P.S. and Paik, H.D. (2017) Anti-Inflammatory and Anti-Genotoxic Activity of Branched Chain Amino Acids (BCAA) in Lipopolysaccharide (LPS) Stimulated RAW 264.7 Macrophages. Food Science and Biotechnology, 26, 1371-1377. https://doi.org/10.1007/s10068-017-0165-4
Costello, L.C. and Franklin, R.B. (2012) Cytotoxic/Tumor Suppressor Role of Zinc for the Treatment of Cancer: An Enigma and an Opportunity. Expert Review of Anticancer Therapy, 12, 121-128. https://doi.org/10.1586/era.11.190
Cheng, J. and Ouwehand, A.C. (2020) Gastroesophageal Reflux Disease and Probiotics: A Systematic Review. Nutrients, 12, Article No. 132. https://doi.org/10.3390/nu12010132